Home
Mail
News
Sport
Finance
Celebrity
Style
Weather
Mobile
Messenger
Movies
More
Yahoo
Mail
News
Market Data
Crypto
Bank of England
Money Matters
Property
Top Stocks
Work & Management
Industry News
Brexit
My Portfolio
My Screeners
Watchlists
Videos
UK markets closed
FTSE 100
8,172.15
+50.91
(+0.63%)
FTSE 250
20,032.56
+105.97
(+0.53%)
AIM
768.19
+3.21
(+0.42%)
GBP/EUR
1.1681
-0.0003
(-0.02%)
GBP/USD
1.2505
-0.0019
(-0.15%)
Bitcoin GBP
47,361.00
+1,877.80
(+4.13%)
Money
Best UK mortgage deals of the week
The cheapest home loans available now
Adaptimmune Therapeutics plc (ADAP)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.2050
-0.0050
(-0.41%)
As of 11:48AM EDT. Market open.
Summary
Chart
Conversations
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
60,281
60,281
27,148
6,149
3,958
Operating expenses
Research development
126,509
126,509
127,726
111,090
91,568
Selling general and administrative
71,810
71,810
61,090
57,305
45,795
Total operating expenses
198,319
198,319
188,816
168,395
137,363
Operating income or loss
-138,038
-138,038
-161,668
-162,246
-133,405
Total other income/expenses net
19,539
19,539
-2,833
3,852
1,162
Income before tax
-112,535
-112,535
-162,959
-157,299
-129,930
Income tax expense
1,336
1,336
2,497
791
162
Income from continuing operations
-113,871
-113,871
-165,456
-158,090
-130,092
Net income
-113,871
-113,871
-165,456
-158,090
-130,092
Net income available to common shareholders
-113,871
-113,871
-165,456
-158,090
-130,092
Basic EPS
-0.54
-0.54
-1.02
-1.02
-0.90
Diluted EPS
-0.54
-0.54
-1.02
-1.02
-0.90
Basic average shares
185,262
201,073
161,207
155,806
142,464
Diluted average shares
185,262
201,073
161,207
155,806
142,464
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.